Issue No. 43

 

FDA Approves New Test to Diagnose HIV Infection

On October 5, 2006, the Food and Drug Administration (FDA) announced that the APTIMA HIV-1 RNA Qualitative Assay is the first HIV-1 RNA detection test approved to help diagnose HIV-1 infection.  The APTIMA assay detects HIV-1 virus circulating in the blood, and can be used to detect HIV infection earlier than HIV antibody tests.  Read the FDA press release here. 

 

Fall 2006 Issue of “Mental Health AIDS” Includes Toolbox on Awareness of “Escaping” HIV Prevention

Biopsychosocial therapy involves assessing an individual patient’s biological, psychological, and social condition to help determine treatment.  “Mental Health AIDS” is a quarterly biopsychosocial research update on HIV and mental health sponsored by the Center for Mental Health Services (CMS) of the Substance Abuse and Mental Health Services Administration (SAMHSA).  This publication is provided free-of-charge through the SAMHSA Web site in both PDF and HTML formats.

The Fall 2006 issue features the “New Thinking on Not Thinking about HIV Risk” tool box, which explores why some people may not think about HIV risk and the consequences for education and prevention efforts.  The tool box also addresses how interventions may be modified to be more successful for certain target groups.

 

 

ClinicalTrials.gov Info

Please send comments or suggestions to ContactUs@aidsinfo.nih.gov

ISSN 1558-3228